SCHEMBL15958680

SCHEMBL15958680

CCOc1nc2cc(C)c(C)cc2nc1-c1cccs1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.52
NPC1 O15118 3/20 0.52
RPS6KB2 Q9UBS0 7/20 0.51
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
PGK1 P00558 1/20 0.43
ALDH1A1 P00352 5/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 2/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 6/20 0.39
SRPK1 Q96SB4 1/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPT P10636 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13595008 0.88 PGK1 (0.53) RAB9ANPC1RPS6KB2ADORA2AADORA1
SCHEMBL8380271 0.87 RPS6KB2 (0.49) RAB9ANPC1RPS6KB2ADORA2AADORA1
SCHEMBL8381174 0.86 RPS6KB2 (0.72) RAB9ANPC1RPS6KB2ADORA2AADORA1
SCHEMBL13595005 0.84 RPS6KB2 (0.46) RAB9ANPC1RPS6KB2ADORA2AADORA1
SCHEMBL13595006 0.83 RPS6KB2 (0.52) RAB9ANPC1RPS6KB2PGK1ALDH1A1
SCHEMBL13595011 0.83 RPS6KB2 (0.52) RAB9ANPC1RPS6KB2PGK1ALDH1A1
SCHEMBL13595037 0.83 RPS6KB2 (0.69) RAB9ANPC1RPS6KB2ADORA2AADORA1
SCHEMBL6236081 0.82 RPS6KB2 (0.70) RAB9ANPC1RPS6KB2ADORA2AADORA1
SCHEMBL15958293 0.81 RPS6KB2 (0.51) RAB9ANPC1RPS6KB2ADORA2AADORA1
SCHEMBL8380340 0.81 ADORA2A (0.50) RAB9ANPC1RPS6KB2ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809264-B2 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2014-08-19 US disclosed